Abstract #22: Impact of somatic TP53 mutation type on benefit from bevacizumab in patients with ovarian cancer, a secondary analysis of NRG/GOG-0218
Titel:
Abstract #22: Impact of somatic TP53 mutation type on benefit from bevacizumab in patients with ovarian cancer, a secondary analysis of NRG/GOG-0218
Auteur:
Thiel, Kristina W. Enserro, Danielle Ghezelayagh, Talayeh Radke, Marc Swisher, Elizabeth Tewari, Krishnansu Copeland, Larry J. Gray, Heidi Ueland, Frederick Konecny, Gottfried Thaker, Premal Wahner-Hendrickson, Andrea Lankes, Heather Bookman, Michael Birrer, Michael Norquist, Barbara Leslie, Kimberly